MALAT1 and liver dysplastic nodule: For example, lncRNA MALAT1 expression is increased in experimental DN and MALAT1 inhibition attenuates high glucose (HG)-induced podocyte injury by regulating Wnt/β-catenin signaling (Gutschner, Hämmerle & Diederichs, 2013; Hu et al., 2017).